HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 113 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,376,000 | -27.4% | 155,248 | +3.5% | 0.00% | – |
Q2 2022 | $1,896,000 | -33.2% | 149,981 | 0.0% | 0.00% | – |
Q1 2022 | $2,838,000 | -46.1% | 149,981 | 0.0% | 0.00% | – |
Q4 2021 | $5,261,000 | -7.9% | 149,981 | -3.9% | 0.00% | – |
Q3 2021 | $5,713,000 | +7.2% | 156,048 | +15.0% | 0.00% | – |
Q2 2021 | $5,328,000 | +22.7% | 135,687 | -11.7% | 0.00% | – |
Q1 2021 | $4,342,000 | -10.8% | 153,728 | +1.1% | 0.00% | – |
Q4 2020 | $4,867,000 | +13.9% | 151,994 | +14.9% | 0.00% | – |
Q3 2020 | $4,273,000 | +18.6% | 132,305 | +1.3% | 0.00% | – |
Q2 2020 | $3,603,000 | +58.4% | 130,658 | +2.6% | 0.00% | – |
Q1 2020 | $2,274,000 | -29.2% | 127,360 | -0.6% | 0.00% | – |
Q4 2019 | $3,213,000 | +25.6% | 128,128 | -10.7% | 0.00% | – |
Q3 2019 | $2,559,000 | -9.3% | 143,426 | +11.9% | 0.00% | – |
Q2 2019 | $2,820,000 | -35.1% | 128,207 | -9.8% | 0.00% | – |
Q1 2019 | $4,347,000 | +38.7% | 142,162 | +4.7% | 0.00% | – |
Q4 2018 | $3,135,000 | – | 135,761 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zeal Asset Management Ltd | 2,684,118 | $84,523,000 | 16.48% |
Cederberg Capital Ltd | 3,400,000 | $108,868,000 | 2.00% |
Capital International Sarl | 570,500 | $18,267,000 | 1.91% |
AIA Group Ltd | 437,118 | $14,971,000 | 1.72% |
Capital International, Inc./CA/ | 4,711,405 | $150,859,000 | 1.40% |
M&G INVESTMENT MANAGEMENT LTD | 3,096,345 | $99,083,000 | 0.62% |
Bellevue Group AG | 947,674 | $30,345,000 | 0.35% |
Sands Capital Management | 7,051,916 | $225,802,000 | 0.22% |
E Fund Management (Hong Kong) Co., Ltd. | 18,836 | $603,000 | 0.21% |
Hudson Bay Capital Management LP | 1,031,212 | $33,020,000 | 0.18% |